General Information of the Compound
| Compound ID |
CP0084070
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(4-Chloro-6-methoxy-2-methyl-pyrimidin-5-yl)-imidazolidin-2-ylidene-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine hydrate hydrochloride
AC1OCENE
BDF-5895
BE-5895
LY-326869
MOXONIDINE
Moxonidine hydrochloride hydrate
Normoxin
SCHEMBL1230620
moxonidine hydrochloride monohydrate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H12ClN5O
|
||||||||||||||||||
| Molecular Weight |
241.682
|
||||||||||||||||||
| Canonical SMILES |
COc1nc(C)nc(Cl)c1N=C1NCCN1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WPNJAUFVNXKLIM-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
75438-57-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT02100, Nischarin
Clinical Information about the Compound